My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 312

    1.

    Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.

    De Block CE, Colpin G, Thielemans K, Coopmans W, Bogers JJ, Pelckmans PA, Van Marck EA, Van Hoof V, Martin M, De Leeuw IH, Bouillon R, Van Gaal LF.

    Diabetes Care. 2004 Jun;27(6):1387-93.PMID: 15161793 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.

    Sanduleanu S, De Bruïne A, Stridsberg M, Jonkers D, Biemond I, Hameeteman W, Lundqvist G, Stockbrügger RW.

    Eur J Clin Invest. 2001 Sep;31(9):802-11.PMID: 11589723 [PubMed - indexed for MEDLINE]Related articles

    3.

    Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings.

    De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, Van Acker KL, Van Gaal LF.

    Diabetes Care. 2003 Jan;26(1):82-8.PMID: 12502662 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.

    Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, De Herder WW, Krenning EP, Bouillon R, Lamberts SW.

    J Clin Endocrinol Metab. 1997 Aug;82(8):2622-8.PMID: 9253344 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.

    Peracchi M, Gebbia C, Basilisco G, Quatrini M, Tarantino C, Vescarelli C, Massironi S, Conte D.

    Eur J Endocrinol. 2005 Mar;152(3):443-8.PMID: 15757862 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors.

    Bajetta E, Ferrari L, Martinetti A, Celio L, Procopio G, Artale S, Zilembo N, Di Bartolomeo M, Seregni E, Bombardieri E.

    Cancer. 1999 Sep 1;86(5):858-65.PMID: 10463986 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.

    Nisman B, Heching N, Biran H, Barak V, Peretz T.

    Tumour Biol. 2006;27(1):8-16. Epub 2005 Dec 8.PMID: 16340245 [PubMed - indexed for MEDLINE]Related articles

    8.

    Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

    Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, Lamers C, Stockbrügger RW.

    Aliment Pharmacol Ther. 1999 Feb;13(2):145-53.PMID: 10102943 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Development of silent gastric carcinoid in a type 1 diabetic patient with primer hypothyreosis]

    Somogyi A, Ruzicska E, Varga T, Rácz K, Nagy G.

    Orv Hetil. 2007 Sep 2;148(35):1667-71. Hungarian. PMID: 17720674 [PubMed - indexed for MEDLINE]Related articles

    10.

    Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes.

    De Block CE, Van Campenhout CM, De Leeuw IH, Keenoy BM, Martin M, Van Hoof V, Van Gaal LF.

    Diabetes Care. 2000 Sep;23(9):1384-8.PMID: 10977038 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor.

    Kleveland O, Syversen U, Slørdahl K, Waldum HL.

    Digestion. 2001;64(2):71-4.PMID: 11684818 [PubMed - indexed for MEDLINE]Related articles

    12.

    Neuroendocrine serum tumour markers in hormone-resistant prostate cancer.

    Hvamstad T, Jordal A, Hekmat N, Paus E, Fosså SD.

    Eur Urol. 2003 Aug;44(2):215-21.PMID: 12875941 [PubMed - indexed for MEDLINE]Related articles

    13.

    Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.

    Baudin E, Gigliotti A, Ducreux M, Ropers J, Comoy E, Sabourin JC, Bidart JM, Cailleux AF, Bonacci R, Ruffié P, Schlumberger M.

    Br J Cancer. 1998 Oct;78(8):1102-7.PMID: 9792158 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Clinical significance of elevated serum chromogranin A levels.

    Syversen U, Ramstad H, Gamme K, Qvigstad G, Falkmer S, Waldum HL.

    Scand J Gastroenterol. 2004 Oct;39(10):969-73.PMID: 15513336 [PubMed - indexed for MEDLINE]Related articles

    15.

    Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis.

    Alonso N, Granada ML, Salinas I, Reverter JL, Flores L, Ojanguren I, Martínez-Cáceres EM, Sanmartí A.

    Eur J Endocrinol. 2007 Dec;157(6):763-9.PMID: 18057384 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.

    Azzoni C, Doglioni C, Viale G, Delle Fave G, De Boni M, Caruana P, Ferraro G, Bordi C.

    Am J Surg Pathol. 1996 Apr;20(4):433-41.PMID: 8604810 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.

    Goebel SU, Serrano J, Yu F, Gibril F, Venzon DJ, Jensen RT.

    Cancer. 1999 Apr 1;85(7):1470-83.PMID: 10193936 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Neuroendocrine differentiation in colorectal carcinomas.

    Syversen U, Halvorsen T, Mårvik R, Waldum HL.

    Eur J Gastroenterol Hepatol. 1995 Jul;7(7):667-74.PMID: 8590163 [PubMed - indexed for MEDLINE]Related articles

    19.

    Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.

    Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E.

    Ann Oncol. 2001;12 Suppl 2:S69-72.PMID: 11762355 [PubMed - indexed for MEDLINE]Related articles

    20.

    Chromogranin A: is it a useful marker of neuroendocrine tumors?

    Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P.

    J Clin Oncol. 2007 May 20;25(15):1967-73.PMID: 17513802 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity